EGFR exon 18 delE709_T710insD mutated stage IV lung adenocarcinoma with response to afatinib

Title
EGFR exon 18 delE709_T710insD mutated stage IV lung adenocarcinoma with response to afatinib
Authors
Keywords
Lung cancer, EGFR mutation, Afatinib, Tyrosine kinase inhibitor, Exon 18, delE709_T710insD
Journal
LUNG CANCER
Volume 108, Issue -, Pages 45-47
Publisher
Elsevier BV
Online
2017-03-02
DOI
10.1016/j.lungcan.2017.02.023

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now